At the molecular level, melanoma pathogenesis is driven by genetic alterations in pathways that regulate proliferation, differentiation and apoptosis, with recurrent mutations in genes such as BRAF, NRAS, NF1, KIT, TERT, and CDKN2A [8,9]. The gene discussed is CDKN2A; the disease is melanoma.